Thibaut Brugat

Company: Domain Therapeutics

Job title: Head of Portfolio

Seminars:

PAR2 in Immuno-oncology: From Target Identification to the Selection of a Candidate with a Superior Mode of Action 9:00 am

Target identification through public and proprietary clinical data Target validation with relevant in vivo models Understanding of receptor biology and thorough benchmark to determine the optimal mechanism of actionRead more

day: Conference Day Two